Featured Research

from universities, journals, and other organizations

Aspirin Use May Be Associated With Increased Risk Of Pancreatic Cancer

Date:
January 7, 2004
Source:
Journal Of The National Cancer Institute
Summary:
Active smoking appears to play a larger role in the development of breast cancer than previously thought, according to a study in the January 7 issue of the Journal of the National Cancer Institute.

Regular aspirin use for 20 years or more may be associated with an increased risk of pancreatic cancer in women, the fourth leading cause of cancer-related deaths in the United States, according to a study in the January 7 issue of the Journal of the National Cancer Institute. Many studies have found that use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced risk of several cancers and precancerous lesions. Past studies in human cells and in laboratory animals have suggested that aspirin and NSAIDs may inhibit the development of pancreatic cancer. However, few studies have examined the association between analgesic use and pancreatic cancer in humans, and results have been inconsistent.

Eva S. Schernhammer, M.D., Dr.P.H., of the Brigham and Women's Hospital and Harvard Medical School in Boston, and her colleagues examined the association between aspirin use and risk of pancreatic cancer among 88,378 women participating in the Nurses' Health Study. The information used in the study was based on questions about aspirin use asked on biennial questionnaires beginning in 1980. Among those women, 34% were current regular aspirin users, defined as women who took two or more 325 mg aspirin tablets per week. The remaining women were non-regular aspirin users who took less than 2 tablets per week.

During 18 years of follow-up, there were 161 new cases of pancreatic cancer. Overall, there was no statistically significant difference in risk of pancreatic cancer between aspirin users and nonusers. However, when the investigators examined the information based on the duration that the women had been taking aspirin, they found that women who reported more than 20 years of regular aspirin use had a 58% increased risk of pancreatic cancer compared with women who never regularly consumed more than two aspirin tablets per week.

When the investigators compared women who had reported consistent, regular aspirin use with women who were non-users during the same time period, they found that the risk of pancreatic cancer increased with increasing aspirin dose. Compared with nonusers, women who took 14 or more aspirin tablets per week had an 86% increased risk of pancreatic cancer.

"Our findings do not support a protective effect of analgesics use on the risk of pancreatic cancer. Rather, aspirin appears to increase the risk of pancreatic cancer after extended periods of use," the authors write. "Risks and benefits associated with the use of aspirin have to be weighed carefully in any recommendations made by health care providers."

In an accompanying editorial, John A. Baron, M.D., of Dartmouth Medical School, writes, "There are no easy answers to the question of what aspirin and other NSAIDs do to pancreatic carcinogenesis. The findings by Schernhammer et al. are provocative and force us to think carefully about the actions of aspirin and other NSAIDs and the mechanisms underlying pancreatic cancer. Fortunately, conflicting data from diverse threads of research are often a very effective push toward scientific progress."

###

Schernhammer ES, Kang J, Chan AT, Michaud DS, Skinner HG, Giovanucci E, et al. A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst 2003;96:22–8.

Editorial: Baron JA. What now for aspirin and cancer prevention? J Natl Cancer Inst 2003;96:4–5.

Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jncicancerspectrum.oupjournals.org/.


Story Source:

The above story is based on materials provided by Journal Of The National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal Of The National Cancer Institute. "Aspirin Use May Be Associated With Increased Risk Of Pancreatic Cancer." ScienceDaily. ScienceDaily, 7 January 2004. <www.sciencedaily.com/releases/2004/01/040107074621.htm>.
Journal Of The National Cancer Institute. (2004, January 7). Aspirin Use May Be Associated With Increased Risk Of Pancreatic Cancer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2004/01/040107074621.htm
Journal Of The National Cancer Institute. "Aspirin Use May Be Associated With Increased Risk Of Pancreatic Cancer." ScienceDaily. www.sciencedaily.com/releases/2004/01/040107074621.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins